Mr Samuel M. Lawrence is the Chief Executive Officer and a Co-Founder of CytoViva, Inc., based in Auburn, AL. Mr. Lawrence led the development of the core, patented illumination technology which is the foundation for CytoViva’s products. He continues to lead all product development efforts as well as actively support the company’s sales efforts both domestically and internationally. Mr. Lawrence is also the CEO of Aetos Technologies, Inc., a technology development company located in Auburn, AL.
Prior to CytoViva, Mr. Lawrence was a Director at Boeing Commercial Airplanes in Seattle, WA where he led Supply Chain Transformation for the 737/757 Programs and was Factory Manager of the Interiors Responsibility Center. Prior to Boeing, Mr. Lawrence worked with Deloitte & Touche, LLC as a management consultant. Mr. Lawrence began his career in 1986 as an engineer on the Boeing Commercial Airplanes Aerodynamics Staff after graduating from Mississippi State University with a Bachelor of Science degree in Aerospace Engineering. He is co-inventor on two U.S. Patents for his work on innovative insulation materials for commercial airplanes. Mr. Lawrence left Boeing in 1991 to continue his education at the Northwestern University Kellogg Graduate School of Management where he earned a Masters of Management in Manufacturing in 1993. Mr. Lawrence also completed the International Executive Programme at INSEAD (Fontainebleau, France/Singapore) in 2002. In 2011 he was named a Distinguished Engineering Fellow at Mississippi State University and in 2014 he was admitted to the Auburn University chapter of the National Academy of Inventors.
Combining High Efficiency Darkfield Illumination and Hyperspectral Imaging to Map Delivery of Nano-Scale Therapeutic Agents in Complex Cell Structures
Friday, 11 September 2015 at 12:20
Add to Calendar ▼2015-09-11 12:20:002015-09-11 13:20:00Europe/LondonCombining High Efficiency Darkfield Illumination and Hyperspectral Imaging to Map Delivery of Nano-Scale Therapeutic Agents in Complex Cell StructuresNanoPharmaceuticals in HyderabadHyderabadSELECTBIOenquiries@selectbiosciences.com
This
talk will provide an overview of the technologies like high resolution microscope
imaging and spectrophotometry used to create data sets as well as offer
examples of various relevant applications.
Emphasis will be placed on the creation of optical images using Enhanced
Darkfield illumination and the analysis of these images with state-of-the-art
hyperspectral imaging hardware and software.
Several examples of data sets created with this approach will be
discussed as well.
Add to Calendar ▼2015-09-10 00:00:002015-09-11 00:00:00Europe/LondonNanoPharmaceuticalsNanoPharmaceuticals in HyderabadHyderabadSELECTBIOenquiries@selectbiosciences.com